Richard L. Feinstein
2013
In 2013, Richard L. Feinstein earned a total compensation of $6.6K as Vice President Finance and Principal Financial Officer at Enzon Pharmaceuticals.
Compensation breakdown
| Other | $6,637 |
|---|---|
| Total | $6,637 |
Feinstein received $6.6K in other compensation, accounting for 100% of the total pay in 2013.
Rankings
In 2013, Richard L. Feinstein's compensation ranked 12,262nd out of 12,286 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,262 out of 12,286 | 0th |
Division Manufacturing | 4,609 out of 4,612 | 0th |
Major group Chemicals And Allied Products | 1,462 out of 1,462 | 0th |
Industry group Drugs | 1,156 out of 1,156 | 0th |
Industry Biological Products, Except Diagnostic Substances | 196 out of 196 | 0th |
Source: SEC filing on May 15, 2015.
Feinstein's colleagues
We found five more compensation records of executives who worked with Richard L. Feinstein at Enzon Pharmaceuticals in 2013.
2013
Andrew Rackear
Enzon Pharmaceuticals
General Counsel
2013
Aby Buchbinder
Enzon Pharmaceuticals
Former Vice President, Clinical Development
2013
Charles Conover
Enzon Pharmaceuticals
Former Senior Vice President of Research & Development, Program Management
2013
George Hebard
Enzon Pharmaceuticals
Chief Operating Officer
2013
Timothy Daly
Enzon Pharmaceuticals